Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy

Alissa V. Winnard, Christopher Jon Klein, Daniel D. Coovert, Thomas Prior, Audrey Papp, Pamela Snyder, Dennis E. Bulman, Peter N. Ray, Patricia McAndrew, Wendy King, Richard T. Moxley, Jerry R. Mendell, Arthur H M Burghes

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

The clinical progression of Duchenne muscular dystrophy (DMD) patients with deletions can be predicted in 93% of cases by whether the deletion maintains or disrupts the translational reading frame (frameshift hypothesis). We have identified and studied a number of patients who have deletions that do not conform to the translational frame hypothesis. The most common exception to the frameshift hypothesis is the deletion of exons 3 to 7 which disrupts the translational reading frame. We identified a Becker muscular dystrophy (BMD) patient, an intermediate, and a DMD patient with this deletion. In all three cases, dystrophin was detected and localized to the membrane. One DMD patient with an inframe deletion of exons 4-18 produced no dystrophin. One patient with a mild intermediate phenotype and a deletion of exon 45, which shifts the reading frame, produced no dystrophin. Two patients with large inframe deletions had discordant phenotypes (exons 3-41, DMD; exons 13-48, BMD), but both produced dystrophin that localized to the sarcolemma. The DMD patient, 113, indicates that dystrophin with an intact carboxy terminus can be produced in Duchenne patients at levels equivalent to some Beckers. The dystrophin analysis from these patients, together with patients reported in the literature, indicate that more than one domain can localize dystrophin to the sarcolemma. Lastely, the data shows that although most patients show correlation of clinical severity to molecular data, there are rare patients which do not conform.

Original languageEnglish (US)
Pages (from-to)737-744
Number of pages8
JournalHuman Molecular Genetics
Volume2
Issue number6
StatePublished - Jun 1993
Externally publishedYes

Fingerprint

Duchenne Muscular Dystrophy
Deletion
Exception
Membranes
Dystrophin
Exons
Reading Frames
Phenotype
Sarcolemma
Progression
Membrane

ASJC Scopus subject areas

  • Genetics
  • Statistics, Probability and Uncertainty
  • Applied Mathematics
  • Public Health, Environmental and Occupational Health
  • Molecular Biology
  • Genetics(clinical)

Cite this

Winnard, A. V., Klein, C. J., Coovert, D. D., Prior, T., Papp, A., Snyder, P., ... Burghes, A. H. M. (1993). Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Human Molecular Genetics, 2(6), 737-744.

Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. / Winnard, Alissa V.; Klein, Christopher Jon; Coovert, Daniel D.; Prior, Thomas; Papp, Audrey; Snyder, Pamela; Bulman, Dennis E.; Ray, Peter N.; McAndrew, Patricia; King, Wendy; Moxley, Richard T.; Mendell, Jerry R.; Burghes, Arthur H M.

In: Human Molecular Genetics, Vol. 2, No. 6, 06.1993, p. 737-744.

Research output: Contribution to journalArticle

Winnard, AV, Klein, CJ, Coovert, DD, Prior, T, Papp, A, Snyder, P, Bulman, DE, Ray, PN, McAndrew, P, King, W, Moxley, RT, Mendell, JR & Burghes, AHM 1993, 'Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy', Human Molecular Genetics, vol. 2, no. 6, pp. 737-744.
Winnard, Alissa V. ; Klein, Christopher Jon ; Coovert, Daniel D. ; Prior, Thomas ; Papp, Audrey ; Snyder, Pamela ; Bulman, Dennis E. ; Ray, Peter N. ; McAndrew, Patricia ; King, Wendy ; Moxley, Richard T. ; Mendell, Jerry R. ; Burghes, Arthur H M. / Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. In: Human Molecular Genetics. 1993 ; Vol. 2, No. 6. pp. 737-744.
@article{b8c1be4e88d34d01a551bd3e1c184cdb,
title = "Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy",
abstract = "The clinical progression of Duchenne muscular dystrophy (DMD) patients with deletions can be predicted in 93{\%} of cases by whether the deletion maintains or disrupts the translational reading frame (frameshift hypothesis). We have identified and studied a number of patients who have deletions that do not conform to the translational frame hypothesis. The most common exception to the frameshift hypothesis is the deletion of exons 3 to 7 which disrupts the translational reading frame. We identified a Becker muscular dystrophy (BMD) patient, an intermediate, and a DMD patient with this deletion. In all three cases, dystrophin was detected and localized to the membrane. One DMD patient with an inframe deletion of exons 4-18 produced no dystrophin. One patient with a mild intermediate phenotype and a deletion of exon 45, which shifts the reading frame, produced no dystrophin. Two patients with large inframe deletions had discordant phenotypes (exons 3-41, DMD; exons 13-48, BMD), but both produced dystrophin that localized to the sarcolemma. The DMD patient, 113, indicates that dystrophin with an intact carboxy terminus can be produced in Duchenne patients at levels equivalent to some Beckers. The dystrophin analysis from these patients, together with patients reported in the literature, indicate that more than one domain can localize dystrophin to the sarcolemma. Lastely, the data shows that although most patients show correlation of clinical severity to molecular data, there are rare patients which do not conform.",
author = "Winnard, {Alissa V.} and Klein, {Christopher Jon} and Coovert, {Daniel D.} and Thomas Prior and Audrey Papp and Pamela Snyder and Bulman, {Dennis E.} and Ray, {Peter N.} and Patricia McAndrew and Wendy King and Moxley, {Richard T.} and Mendell, {Jerry R.} and Burghes, {Arthur H M}",
year = "1993",
month = "6",
language = "English (US)",
volume = "2",
pages = "737--744",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy

AU - Winnard, Alissa V.

AU - Klein, Christopher Jon

AU - Coovert, Daniel D.

AU - Prior, Thomas

AU - Papp, Audrey

AU - Snyder, Pamela

AU - Bulman, Dennis E.

AU - Ray, Peter N.

AU - McAndrew, Patricia

AU - King, Wendy

AU - Moxley, Richard T.

AU - Mendell, Jerry R.

AU - Burghes, Arthur H M

PY - 1993/6

Y1 - 1993/6

N2 - The clinical progression of Duchenne muscular dystrophy (DMD) patients with deletions can be predicted in 93% of cases by whether the deletion maintains or disrupts the translational reading frame (frameshift hypothesis). We have identified and studied a number of patients who have deletions that do not conform to the translational frame hypothesis. The most common exception to the frameshift hypothesis is the deletion of exons 3 to 7 which disrupts the translational reading frame. We identified a Becker muscular dystrophy (BMD) patient, an intermediate, and a DMD patient with this deletion. In all three cases, dystrophin was detected and localized to the membrane. One DMD patient with an inframe deletion of exons 4-18 produced no dystrophin. One patient with a mild intermediate phenotype and a deletion of exon 45, which shifts the reading frame, produced no dystrophin. Two patients with large inframe deletions had discordant phenotypes (exons 3-41, DMD; exons 13-48, BMD), but both produced dystrophin that localized to the sarcolemma. The DMD patient, 113, indicates that dystrophin with an intact carboxy terminus can be produced in Duchenne patients at levels equivalent to some Beckers. The dystrophin analysis from these patients, together with patients reported in the literature, indicate that more than one domain can localize dystrophin to the sarcolemma. Lastely, the data shows that although most patients show correlation of clinical severity to molecular data, there are rare patients which do not conform.

AB - The clinical progression of Duchenne muscular dystrophy (DMD) patients with deletions can be predicted in 93% of cases by whether the deletion maintains or disrupts the translational reading frame (frameshift hypothesis). We have identified and studied a number of patients who have deletions that do not conform to the translational frame hypothesis. The most common exception to the frameshift hypothesis is the deletion of exons 3 to 7 which disrupts the translational reading frame. We identified a Becker muscular dystrophy (BMD) patient, an intermediate, and a DMD patient with this deletion. In all three cases, dystrophin was detected and localized to the membrane. One DMD patient with an inframe deletion of exons 4-18 produced no dystrophin. One patient with a mild intermediate phenotype and a deletion of exon 45, which shifts the reading frame, produced no dystrophin. Two patients with large inframe deletions had discordant phenotypes (exons 3-41, DMD; exons 13-48, BMD), but both produced dystrophin that localized to the sarcolemma. The DMD patient, 113, indicates that dystrophin with an intact carboxy terminus can be produced in Duchenne patients at levels equivalent to some Beckers. The dystrophin analysis from these patients, together with patients reported in the literature, indicate that more than one domain can localize dystrophin to the sarcolemma. Lastely, the data shows that although most patients show correlation of clinical severity to molecular data, there are rare patients which do not conform.

UR - http://www.scopus.com/inward/record.url?scp=0027207248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027207248&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 737

EP - 744

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 6

ER -